Additional analysis including only patients with oropharyngeal cancer (n = 79) revealed a shorter DFS for methylated than for unmethylated PTGIR and TBXA2R (log-rank test, P = 0.003 and P = 0.009, respectively; Additional file 8: Fig. S4C, D). Here, PTGIR is linked to oropharynx cancer.